CDKN2A promoter hypermethylation occurs in uveal melanoma [29] and cutaneous melanoma [28]; p14ARF expression is inversely correlated with melanoma progression since its expression decreases in the progression from melanocytic nevi to the metastatic state [49]. This evidence concerns the gene CDKN2A and melanoma.